Skip to content
2000
Volume 21, Issue 3
  • ISSN: 1573-398X
  • E-ISSN: 1875-6387

Abstract

Background and Objective

Tuberculosis (TB) was one of the most challenging diseases in terms of diagnosis, treatment, and control during the COVID-19 pandemic. The present study was conducted to investigate the impact of the COVID-19 pandemic on the incidence of tuberculosis.

Materials and Methods

This study was cross-sectional, based on a census of all patients with tuberculosis whose information was available in the tuberculosis registration system of the Health Vice-Chancellor of Jiroft University of Medical Sciences from 2016 to 2021. In this study, demographic information and variables related to the type of tuberculosis, disease case, treatment result, and treatment regimen were collected using a researcher-made questionnaire.

Results

The incidence of tuberculosis during the COVID-19 pandemic was significantly reduced by 57% compared to the pre-pandemic period. There was no significant difference between the pre-COVID-19 era and the pandemic era in terms of demographic variables and several determining factors in TB patients.

Conclusion

The COVID-19 pandemic was found to impact the control of the tuberculosis program. Delays in referral, diagnosis, and treatment led to an increase in the spread of tuberculosis, particularly within households, an increase in the number of deaths, and an increase in drug resistance of the tuberculosis microbe. Therefore, it is recommended that awareness programs for the public about tuberculosis be organized and that more education be provided to health and treatment staff about tuberculosis to ensure that the control measures implemented in recent decades are not wasted.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/crmr/10.2174/011573398X318641240914123736
2025-01-02
2025-11-06

  • From This Site

    /content/journals/crmr/10.2174/011573398X318641240914123736
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WorobeyM. LevyJ.I. Malpica SerranoL. Crits-ChristophA. PekarJ.E. GoldsteinS.A. RasmussenA.L. KraemerM.U.G. NewmanC. KoopmansM.P.G. SuchardM.A. WertheimJ.O. LemeyP. RobertsonD.L. GarryR.F. HolmesE.C. RambautA. AndersenK.G. The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic.Science2022377660995195910.1126/science.abp871535881010
     [Google Scholar]
  2. RaesiR. AbbasiZ. RaeiM. HushmandiK. The relationship between the incidence of COVID-19 with the underlying diseases in hospitalized patients.EBNESINA20222437580
     [Google Scholar]
  3. YuB. ChenX. RichS. MoQ. YanH. YanH. Dynamics of the coronavirus disease 2019 (COVID-19) epidemic in Wuhan City, Hubei Province and China: A second derivative analysis of the cumulative daily diagnosed cases during the first 85 days.Global Health J.20215141110.1016/j.glohj.2021.02.00133585050
     [Google Scholar]
  4. LiuP. NiuR. ChenJ. TangY. TangW. XuL. FengJ. Epidemiological and clinical features in patients with coronavirus disease 2019 outside of Wuhan, China: Special focus in asymptomatic patients.PLoS Negl. Trop. Dis.2021153e000924810.1371/journal.pntd.000924833690662
     [Google Scholar]
  5. AbbasiZ. SaghariS. NashtifaniA.H. DaneshiS. HushmandiK. RaesiR. Frequency distribution of depression and its associated factors among pregnant women during the COVID-19 pandemic.Open Public Health J.2023161e1874944525283010.2174/0118749445252830231026060947
     [Google Scholar]
  6. DaneshF. GhavidelS. Coronavirus: Scientometrics of 50 years of global scientific productions.Iran. J. Med. Microbiol.202014111610.30699/ijmm.14.1.1
     [Google Scholar]
  7. FaryabiR. RahimiT. DaneshiS. MovahedE. YusefiA.R. ShahrokhabadiM.S. ChenD-G.D. AzaraeenS. ClarkC.C.T. Stress coping styles in family and relatives of coronavirus disease 2019 (COVID-19) patients in the south of Iran: Application of Lazarus and Folkman’s theory of stress coping.Open Public Health J.2022151e18749445220921010.2174/18749445‑v15‑e220927‑2021‑243
     [Google Scholar]
  8. AskarpourH. DomariA.A. JafarnejadA. Hejazi FardS.N. HashemiM. FaryabiR. Evaluation of Health-promoting Lifestyles in Iranian students during the COVID-19 Epidemic: An Observational Study.Open Public Health J.2023161
     [Google Scholar]
  9. TavakoliA. Incidence and prevalence of tuberculosis in Iran and neighboring countries.Zahedan J. Res. Med. Sci.201719710.5812/zjrms.9238
     [Google Scholar]
  10. MerzaM.A. FarniaP. SalihA.M. MasjediM.R. VelayatiA.A. The most predominant spoligopatterns of Mycobacterium tuberculosis isolates among Iranian, Afghan-immigrant, Pakistani and Turkish tuberculosis patients: A comparative analysis.Chemotherapy201056324825710.1159/00031684620551642
     [Google Scholar]
  11. JimmaW. GhazisaeediM. ShahmoradiL. AbdurahmanA.A. KalhoriS.R.N. NasehiM. YazdiS. SafdariR. Prevalence of and risk factors for multidrug-resistant tuberculosis in Iran and its neighboring countries: Systematic review and meta-analysis.Rev. Soc. Bras. Med. Trop.201750328729510.1590/0037‑8682‑0002‑201728700044
     [Google Scholar]
  12. BialvaeiA.Z. AsgharzadehM. AghazadehM. NourazarianM. KafilH.S. Challenges of tuberculosis in Iran.Jundishapur J Microbiol2017103e15558
     [Google Scholar]
  13. RaesiR. BokaieS. HushmandiK. RaeiM. Evaluation of patients’ satisfaction with the diagnosis of COVID-19 from the quality of nursing services in corona ward: A cross-sectional study.J. Critic. Care Nurs.20221512533
     [Google Scholar]
  14. ChakayaJ. KhanM. NtoumiF. AklilluE. FatimaR. MwabaP. KapataN. MfinangaS. HasnainS.E. KatotoP.D.M.C. BulabulaA.N.H. Sam-AguduN.A. NachegaJ.B. TiberiS. McHughT.D. AbubakarI. ZumlaA. Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts.Int. J. Infect. Dis.2021113Suppl. 1S7S1210.1016/j.ijid.2021.02.10733716195
     [Google Scholar]
  15. SorvorF.K.B. EwusieE.A. The impact of genexpert MTB/RIF technology on the minimization of tuberculosis: A review of literature.Asian J. Med. Health202422111210.9734/ajmah/2024/v22i1969
     [Google Scholar]
  16. MishraA. A Novel Model of "Remedy and Elimination of Tuberculosis" [Master's thesis].San Francisco, CA: University of San Francisco; 2017. Available from: https://repository.usfca.edu/thes/1118/
     [Google Scholar]
  17. WHOTuberculosis control in the South-East Asia region.2015Available From: https://iris.who.int/handle/10665/205286
  18. GlaziouP. FloydK. RaviglioneM.C. Global epidemiology of tuberculosis. Semin Respir Crit Care Med. 2018; 39(3): 271-285.10.1055/s‑0038‑1651492.
  19. DaviesP.D.O. The world-wide increase in tuberculosis: How demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis.Ann. Med.200335423524310.1080/0785389031000571312846265
     [Google Scholar]
  20. BhargavaA. BhargavaM. Tuberculosis deaths are predictable and preventable: Comprehensive assessment and clinical care is the key.J. Clin. Tuberc. Other Mycobact. Dis.20201910015510.1016/j.jctube.2020.10015532211519
     [Google Scholar]
  21. BagcchiS. WHO’s global tuberculosis report 2022.Lancet Microbe202341e2010.1016/S2666‑5247(22)00359‑736521512
     [Google Scholar]
  22. LiangC. YuJ. TangS. Interpretation of the global tuberculosis report 2022 by world health organization. J Diagn Concepts Pract. 2023; 22(1): 21-30.10.16150/j.1671‑2870.2023.01.004
  23. SutharA.B. ZachariahR. HarriesA.D. Ending tuberculosis by 2030: Can we do it?Int. J. Tuberc. Lung Dis.20162091148115410.5588/ijtld.16.014227510238
     [Google Scholar]
  24. PetersenE. BlumbergL. WilsonM.E. ZumlaA. Ending the Global Tuberculosis Epidemic by 2030—The Moscow declaration and achieving a major translational change in delivery of TB healthcare.Int. J. Infect. Dis.20176515615810.1016/j.ijid.2017.11.02929203390
     [Google Scholar]
  25. HarriesA.D. LinY. KumarA.M.V. SatyanarayanaS. TakarindaK.C. DlodloR.A. ZachariahR. OlliaroP.L. What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?F1000 Res.20187101110.12688/f1000research.14821.130026917
     [Google Scholar]
  26. BhargavaA. BhargavaM. JunejaA. Social determinants of tuberculosis: Context, framework, and the way forward to ending TB in India.Expert Rev. Respir. Med.202115786788310.1080/17476348.2021.183246933016808
     [Google Scholar]
  27. DaneshiS. Ebadi Fard AzarF. Ahmadi TabatabaeiS.V. FaryabiR. KamaliA. Sheikh Beig GoharriziM.A. Alian SamakkhahS. HushmandiK. Rezabeigi DavaraniE. Process and outcome evaluation of directly observed treatment short course (DOTs) in Kerman city, Southeast of Iran.Indian J. Tuberc.202269462062510.1016/j.ijtb.2021.09.00136460399
     [Google Scholar]
  28. FelekeB.E. FelekeT.E. BiadglegneF. Nutritional status of tuberculosis patients, a comparative cross-sectional study.BMC Pulm. Med.201919118210.1186/s12890‑019‑0953‑031638950
     [Google Scholar]
  29. KaryadiE. WestC.E. NelwanR.H. DolmansW.M. SchultinkJ.W. van der MeerJ.W. Social aspects of patients with pulmonary tuberculosis in Indonesia.Southeast Asian J. Trop. Med. Public Health200233233834512236434
     [Google Scholar]
  30. Hassan ZadehJ. NasehiM. RezaianzadehA. TabatabaeeH. RajaeifardA. GhaderiE. Pattern of reported tuberculosis cases in iran 2009-2010.Iran. J. Public Health2013421727823514975
     [Google Scholar]
  31. NasehiM HassanzadehJ RezaianzadehA ZeigamiB TabatabaeeH GhaderiE Diagnosis delay in smear positive tuberculosis patients.J. Res. Med. Sci.2012171110014
     [Google Scholar]
  32. BabamahmoodiF AlikhaniA Yazdani CharatiJ GhovvatiA AhangarkaniF DelavarianL Clinical epidemiology and paraclinical findings in tuberculosis patients in north of Iran.Biomed Res Int.201520151138157210.1155/2015/381572
     [Google Scholar]
  33. YinJ. YuanJ. HuY. WeiX. Association between directly observed therapy and treatment outcomes in multidrug-resistant tuberculosis: A systematic review and meta-analysis.PLoS One2016113e015051110.1371/journal.pone.015051126930287
     [Google Scholar]
  34. WeiX-L. YinJ. ZouG-Y. ZhangZ-T. WalleyJ. HarwellJ. LiH-T. SunQ. LiR-Z. WangL-X. ZhangX-L. Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China.Int. J. Tuberc. Lung Dis.201519441341910.5588/ijtld.14.048525859996
     [Google Scholar]
  35. SotgiuG. MiglioriG.B. Facing multi-drug resistant tuberculosis.Pulm. Pharmacol. Ther.20153214414810.1016/j.pupt.2014.04.00624792579
     [Google Scholar]
  36. PrasadR. Management of multi-drug resistant tuberculosis: Practitioner’s view point.Indian J. Tuberc.200754131117455417
     [Google Scholar]
  37. TiberiS. VjechaM.J. ZumlaA. GalvinJ. MiglioriG.B. ZumlaA. Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic.Int. J. Infect. Dis.2021113Suppl. 1S96S9910.1016/j.ijid.2021.02.06733713815
     [Google Scholar]
  38. ZimmerA.J. HeitkampP. MalarJ. DantasC. O’BrienK. PanditaA. WaiteR.C. Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: A community perspective.J. Clin. Tuberc. Other Mycobact. Dis.20212410024810.1016/j.jctube.2021.10024834189276
     [Google Scholar]
  39. ShalahuddinI. PebriantiS. EriyaniT. MaulanaI. Telenursing intervention for pulmonary tuberculosis patients-a scoping review.J. Multidiscip. Healthc.202417577010.2147/JMDH.S44031438196938
     [Google Scholar]
  40. ZhangY. ZhangL. GaoW. LiM. LuoQ. XiangY. BaoK. The impact of COVID-19 pandemic on reported tuberculosis incidence and mortality in China: An interrupted time series analysis.J. Glob. Health2023130604310.7189/jogh.13.0604337824176
     [Google Scholar]
  41. SyK.T.L. HawN.J.L. UyJ. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19.Infect. Dis. (Lond.)2020521290290710.1080/23744235.2020.180635332808838
     [Google Scholar]
  42. ZhangX. AndersenA.B. LillebaekT. Kamper-JørgensenZ. ThomsenV.Ø. LadefogedK. MarrsC.F. ZhangL. YangZ. Effect of sex, age, and race on the clinical presentation of tuberculosis: A 15-year population-based study.Am. J. Trop. Med. Hyg.201185228529010.4269/ajtmh.2011.10‑063021813849
     [Google Scholar]
  43. ZhuM. HanG. TakiffH.E. WangJ. MaJ. ZhangM. LiuS. Times series analysis of age-specific tuberculosis at a rapid developing region in China, 2011–2016.Sci. Rep.201881872710.1038/s41598‑018‑27024‑w29880836
     [Google Scholar]
  44. MarçôaR RibeiroA ZãoI DuarteR. Tuberculosis and gender- Factors influencing the risk of tuberculosis among men and women by age group.Pulmonol. J.2018243199202
     [Google Scholar]
  45. HagiyaH. KoyamaT. ZamamiY. MinatoY. TatebeY. MikamiN. TerataniY. OhshimaA. ShinomiyaK. KitamuraY. SendoT. HinotsuS. TomonoK. KanoM.R. Trends in incidence and mortality of tuberculosis in Japan: A population-based study, 1997–2016.Epidemiol. Infect.2019147e3810.1017/S095026881800290X30409242
     [Google Scholar]
  46. DoddP.J. SismanidisC. GlaziouP. Methods for estimating tuberculosis incidence and mortality by age and sex.Int. J. Epidemiol.202150257057710.1093/ije/dyaa25733624797
     [Google Scholar]
  47. SepehrMM FouladvandF MirzaeiM Evaluation of incidence and TB treatment success rates in yazd province (2005-2014).J. Shahid Sadoughi Univ. Med. Sci.201927818041813
     [Google Scholar]
  48. IliyasuZ. BabashaniM. Prevalence and predictors of tuberculosis coinfection among HIV-seropositive patients attending the Aminu Kano Teaching Hospital, northern Nigeria.J. Epidemiol.2009192818710.2188/jea.JE2008002619265273
     [Google Scholar]
  49. ShahN.S. CavanaughJ.S. PrattR. CainK.P. WellsC. LasersonK. NelsonL. Epidemiology of smear-negative pulmonary tuberculosis in the United States, 1993–2008.Int. J. Tuberc. Lung Dis.20121691234124010.5588/ijtld.11.079422748057
     [Google Scholar]
  50. RaiD. KirtiR. KumarS. KarmakarS. ThakurS. Radiological difference between new sputum-positive and sputum-negative pulmonary tuberculosis.J. Family Med. Prim. Care2019892810281310.4103/jfmpc.jfmpc_652_1931681647
     [Google Scholar]
  51. DaneshiS. Naghibzadeh-TahamiA. RazaghiA.R. SheikhshoaeiM. Rezabeigi DavaraniE. Epidemiologic study of tuberculosis in Kerman city during 2011 â 2015.Health Devel. J.201873218226
     [Google Scholar]
/content/journals/crmr/10.2174/011573398X318641240914123736
Loading
Effects of COVID-19 Pandemic on Pulmonary Tuberculosis (TB) Occurrence in the South of Iran
Curr. Respir. Med. Rev. 21, 267 (2025); https://doi.org/10.2174/011573398X318641240914123736
/content/journals/crmr/10.2174/011573398X318641240914123736
/content/journals/crmr/10.2174/011573398X318641240914123736
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): acute respiratory syndrome; awareness programs; infectious diseases; Tuberculosis (TB), COVID-19 pandemic; tuberculosis microbe

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test